全球心臟驟停治療市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

全球心臟驟停治療市場的需求預計將從 2022 年的 65 億美元增至 2030 年的近 97.6 億美元，2023-2030 年研究期間CAGR為 5.21%。

心臟驟停是一種突然且危及生命的疾病，心臟突然停止有效跳動，導致流向重要器官的血液停止。立即治療對於恢復心臟功能和循環至關重要。

市場動態

心臟驟停治療市場在多種因素的推動下經歷了成長。全球心臟驟停發生率不斷上升，推動了對有效治療和技術的需求。人們對立即心肺復甦術和除顫的關鍵作用的認知不斷提高，再加上促進公共教育的培訓舉措，透過確保更多的人有能力應對緊急情況來推動市場擴張。醫療技術的進步，特別是自動體外心臟去顫器 (AED) 和復甦技術的進步，顯著提高了治療效果，刺激了市場成長。政府強制要求在公共場所和醫療機構安裝 AED 的舉措，以及醫療保健支出和緊急醫療服務投資的增加，都有助於市場擴張。人口老化和隨之而來的心血管疾病的增加推動了對心臟驟停治療的需求。專注於改善患者治療效果、醫療設備技術創新以及對新治療方法的持續研究進一步推動了市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球心臟驟停治療市場的各個細分市場進行了包容性評估。心臟驟停治療產業的成長和趨勢為本研究提供了整體方法。

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲心臟驟停治療市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。心臟驟停治療市場的主要參與者包括輝瑞公司、通用電氣醫療保健、諾華公司、拜耳公司、波士頓科學公司、安進、雅培實驗室等。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

• 報告說明
  • 客觀的
  • 目標受眾
  • 獨特的銷售主張 (USP) 和產品
• 研究範圍
• 研究方法論
  • 市場研究過程
  • 市場研究方法論

第 2 章：執行摘要

• 市場亮點
• 全球市場概況

第 3 章：心臟驟停治療 - 產業分析

• 簡介 - 市場動態
• 市場促進因素
• 市場限制
• 機會
• 產業動態
• 波特五力分析
• 市場吸引力分析
  • 按處理方式進行的市場吸引力分析
  • 按配銷通路分類的市場吸引力分析
  • 市場吸引力分析：按地區

第 4 章：價值鏈分析

• 價值鏈分析
• 原料分析
  • 原料清單
  • 原料廠商清單
  • 主要原物料價格走勢
• 潛在買家名單
• 行銷管道
  • 直效行銷
  • 間接行銷
  • 行銷通路發展趨勢

第 5 章：全球心臟驟停治療市場分析：依治療分類

• 按治療概述
• 歷史和預測數據
• 按治療分析
• 藥物（血管加壓藥、抗心律不整藥物、抗膽鹼能藥物、皮質類固醇、纖溶藥物、BETA受體阻斷劑等）
• 醫療器材（去顫器、心臟再同步治療等）

第 6 章：全球心臟驟停治療市場分析：按分銷管道

• 按配銷通路分類的概覽
• 歷史和預測數據
• 按配銷通路分析
• 醫院
• 藥局
• 其他

第 7 章：全球心臟驟停治療市場分析：按地理位置

• 區域展望
• 介紹
• 北美銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 北美按細分市場銷售分析
  • 北美按國家銷售分析
  • 美國銷售分析
  • 加拿大銷售分析
  • 墨西哥銷售分析
• 歐洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 歐洲按細分市場銷售分析
  • 歐洲按國家銷售分析
  • 英國銷售分析
  • 法國銷售分析
  • 德國銷售分析
  • 義大利銷售分析
  • 俄羅斯銷售分析
  • 歐洲其他地區銷售分析
• 亞太地區銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 亞太地區按細分市場銷售分析
  • 亞太地區國家/地區銷售分析
  • 中國銷售分析
  • 印度銷售分析
  • 日本銷售分析
  • 韓國銷售分析
  • 澳洲銷售分析
  • 東南亞銷售分析
  • 亞太地區其他地區銷售分析
• 拉丁美洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 拉丁美洲按細分市場銷售分析
  • 拉丁美洲按國家銷售分析
  • 巴西銷售分析
  • 阿根廷銷售分析
  • 秘魯銷售分析
  • 智利銷售分析
  • 拉丁美洲其他地區銷售分析
• 中東和非洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 中東和非洲按細分市場銷售分析
  • 中東和非洲國家銷售分析
  • 沙烏地阿拉伯銷售分析
  • 阿拉伯聯合大公國銷售分析
  • 以色列銷售分析
  • 南非銷售分析
  • 中東其他地區和非洲銷售分析

第 8 章：心臟驟停治療公司的競爭格局

• 心臟驟停治療市場競爭
• 夥伴關係/協作/協議
• 併購
• 新產品發布
• 其他發展

第 9 章：公司簡介

• 頂級公司市佔率分析
• 市場集中度
• Pfizer Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• GE Healthcare
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Novartis AG
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Bayer AG
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Boston Scientific Corporation
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Amgen Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Abbott Laboratories
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• 其他
  • 公司簡介
  • 公司收入
  • 產品
  • 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

The global demand for Cardiac Arrest Treatment Market is presumed to reach the market size of nearly USD 9.76 BN by 2030 from USD 6.5 BN in 2022 with a CAGR of 5.21% under the study period 2023 - 2030.

Cardiac arrest is a sudden and life-threatening condition where the heart suddenly stops beating effectively, leading to the cessation of blood flow to vital organs. Immediate treatment is critical to restore the heart's function and circulation.

MARKET DYNAMICS

The Cardiac arrest treatment market experiences growth driven by various factors. The increasing incidence of cardiac arrest globally fuels the demand for effective treatments and technologies. Rising awareness about the critical role of immediate CPR and defibrillation, coupled with training initiatives promoting public education, drives market expansion by ensuring more individuals are equipped to respond to emergencies. Advancements in medical technology, especially in automated external defibrillators (AEDs) and resuscitation techniques, significantly enhance treatment efficacy, stimulating market growth. Government initiatives mandating AED installations in public places and healthcare facilities, alongside increased healthcare spending and investments in emergency medical services, contribute to market expansion. Aging populations and the associated rise in cardiovascular diseases drive demand for cardiac arrest treatments. Efforts focused on improving patient outcomes, technological innovations in medical devices, and ongoing research into new treatment approaches further fuel market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cardiac arrest treatment. The growth and trends of cardiac arrest treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the cardiac arrest treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Treatment

• Drugs (Vasopressors, Anti-Arrhythmic Drugs, Anticholinergic Drugs, Corticosteroids, Fibrinolytic Drugs, Beta Blockers, Others)
• Medical Devices (Defibrillators, Cardiac Resynchronization Therapy, Others)

By Distribution Channel

• Hospitals
• Pharmacies
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cardiac Arrest Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cardiac Arrest Treatment market include Pfizer Inc., GE Healthcare, Novartis AG, Bayer AG, Boston Scientific Corporation, Amgen Inc., Abbott Laboratories, and others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . CARDIAC ARREST TREATMENT - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Treatment
  • 3.7.2 Market Attractiveness Analysis By Distribution Channel
  • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CARDIAC ARREST TREATMENT MARKET ANALYSIS BY TREATMENT

• 5.1 Overview by Treatment
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Treatment
• 5.4 Drugs (Vasopressors, Anti-Arrhythmic Drugs, Anticholinergic Drugs, Corticosteroids, Fibrinolytic Drugs, Beta Blockers, Others) Historic and Forecast Sales by Regions
• 5.5 Medical Devices (Defibrillators, Cardiac Resynchronization Therapy, Others) Historic and Forecast Sales by Regions

6 . GLOBAL CARDIAC ARREST TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL

• 6.1 Overview by Distribution Channel
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Distribution Channel
• 6.4 Hospitals Historic and Forecast Sales by Regions
• 6.5 Pharmacies Historic and Forecast Sales by Regions
• 6.6 Others Historic and Forecast Sales by Regions

7 . GLOBAL CARDIAC ARREST TREATMENT MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.3.2. North America By Segment Sales Analysis
  • 7.3.3. North America By Country Sales Analysis
  • 7.3.4. United State Sales Analysis
  • 7.3.5. Canada Sales Analysis
  • 7.3.6. Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.4.2. Europe by Segment Sales Analysis
  • 7.4.3. Europe by Country Sales Analysis
  • 7.4.4. United Kingdom Sales Analysis
  • 7.4.5. France Sales Analysis
  • 7.4.6. Germany Sales Analysis
  • 7.4.7. Italy Sales Analysis
  • 7.4.8. Russia Sales Analysis
  • 7.4.9. Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.5.2. Asia Pacific by Segment Sales Analysis
  • 7.5.3. Asia Pacific by Country Sales Analysis
  • 7.5.4. China Sales Analysis
  • 7.5.5. India Sales Analysis
  • 7.5.6. Japan Sales Analysis
  • 7.5.7. South Korea Sales Analysis
  • 7.5.8. Australia Sales Analysis
  • 7.5.9. South East Asia Sales Analysis
  • 7.5.10. Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.6.2. Latin America by Segment Sales Analysis
  • 7.6.3. Latin America by Country Sales Analysis
  • 7.6.4. Brazil Sales Analysis
  • 7.6.5. Argentina Sales Analysis
  • 7.6.6. Peru Sales Analysis
  • 7.6.7. Chile Sales Analysis
  • 7.6.8. Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.7.2. Middle East & Africa by Segment Sales Analysis
  • 7.7.3. Middle East & Africa by Country Sales Analysis
  • 7.7.4. Saudi Arabia Sales Analysis
  • 7.7.5. UAE Sales Analysis
  • 7.7.6. Israel Sales Analysis
  • 7.7.7. South Africa Sales Analysis
  • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE CARDIAC ARREST TREATMENT COMPANIES

• 8.1. Cardiac Arrest Treatment Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9 . COMPANY PROFILES OF CARDIAC ARREST TREATMENT INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. Pfizer Inc.
  • 9.3.1. Company Overview
  • 9.3.2. Company Revenue
  • 9.3.3. Products
  • 9.3.4. Recent Developments
• 9.4. GE Healthcare
  • 9.4.1. Company Overview
  • 9.4.2. Company Revenue
  • 9.4.3. Products
  • 9.4.4. Recent Developments
• 9.5. Novartis AG
  • 9.5.1. Company Overview
  • 9.5.2. Company Revenue
  • 9.5.3. Products
  • 9.5.4. Recent Developments
• 9.6. Bayer AG
  • 9.6.1. Company Overview
  • 9.6.2. Company Revenue
  • 9.6.3. Products
  • 9.6.4. Recent Developments
• 9.7. Boston Scientific Corporation
  • 9.7.1. Company Overview
  • 9.7.2. Company Revenue
  • 9.7.3. Products
  • 9.7.4. Recent Developments
• 9.8. Amgen Inc.
  • 9.8.1. Company Overview
  • 9.8.2. Company Revenue
  • 9.8.3. Products
  • 9.8.4. Recent Developments
• 9.9. Abbott Laboratories
  • 9.9.1. Company Overview
  • 9.9.2. Company Revenue
  • 9.9.3. Products
  • 9.9.4. Recent Developments
• 9.10. Others
  • 9.10.1. Company Overview
  • 9.10.2. Company Revenue
  • 9.10.3. Products
  • 9.10.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Treatment (USD MN)
• Drugs (Vasopressors, Anti-Arrhythmic Drugs, Anticholinergic Drugs, Corticosteroids, Fibrinolytic Drugs, Beta Blockers, Others) Market Sales by Geography (USD MN)
• Medical Devices (Defibrillators, Cardiac Resynchronization Therapy, Others) Market Sales by Geography (USD MN)
• Analysis Market by Distribution Channel (USD MN)
• Hospitals Market Sales by Geography (USD MN)
• Pharmacies Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Cardiac Arrest Treatment Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Cardiac Arrest Treatment Report
• Market Research Process
• Market Research Methodology
• Global Cardiac Arrest Treatment Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Treatment
• Market Attractiveness Analysis by Distribution Channel
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Treatment (USD MN)
• Drugs (Vasopressors, Anti-Arrhythmic Drugs, Anticholinergic Drugs, Corticosteroids, Fibrinolytic Drugs, Beta Blockers, Others) Market Sales by Geography (USD MN)
• Medical Devices (Defibrillators, Cardiac Resynchronization Therapy, Others) Market Sales by Geography (USD MN)
• Global Market Analysis by Distribution Channel (USD MN)
• Hospitals Market Sales by Geography (USD MN)
• Pharmacies Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.